Global University Venturing

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Advancing foundational research from UCLA and Migal – Galilee Research Institute, ImmPact is working on T-cell therapies for liquid and solid cancers.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.

The newly launched investment company will exclusively co-invest in spinouts from UCPH.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Porter Alliance for Innovative Medicines will be equipped with $130m to advance research from Stanford’s Innovative Medicines Accelerator.

Richard Chylla will start as executive director of University of Virginia’s Licensing and Ventures Group next week after more than a decade at Michigan State University.